Back
Catalyst Pharmaceuticals Stock Predictions
Sponsored
CPRX
Sponsored
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
CPRX
Catalyst Pharmaceuticals
Last Price:
20.75
Seasonality Move:
-9.09%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Catalyst Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Catalyst Pharmaceuticals has on average historically risen by 32.4% based on the past 17 years of stock performance.
- Catalyst Pharmaceuticals has risen higher in 12 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 70.59%
-
Is Catalyst Pharmaceuticals Stock Undervalued?
The current Catalyst Pharmaceuticals [CPRX] share price is $20.78. The Score for CPRX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal. - CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Catalyst Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Catalyst Pharmaceuticals has on average historically risen by 32.4% based on the past 17 years of stock performance.
Catalyst Pharmaceuticals Stock Rating
Sell
46
Catalyst Pharmaceuticals (CPRX)
is a Sell
Is Catalyst Pharmaceuticals overpriced?
- Catalyst Pharmaceuticals has risen higher in 12 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 70.59%
Catalyst Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
catalystpharma.com
52-Week Data
52-Week High:
21.67
52-Week Low:
11.55
Prediction Charts
Market Cap:
2.47B
Price in USD:
20.78
Volume:
1.81M
Beta:
1.11
Technical Analysis
SMA50:
18.82
SMA100:
17.25
SMA200:
16.18
52-Wk Change:
70.61%
Stock Predictions
-
Is Catalyst Pharmaceuticals stock public?
Yes, Catalyst Pharmaceuticals is a publicly traded company. -
What is the Catalyst Pharmaceuticals stock quote today?
The Catalyst Pharmaceuticals stock price is 20.78 USD today. -
How to buy Catalyst Pharmaceuticals stock online?
You can buy Catalyst Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Sep-3 | 20.20 | 19.74 | 20.37 | 19.74 |
Sep-4 | 19.64 | 19.91 | 20.13 | 19.43 |
Sep-5 | 19.99 | 19.82 | 20.02 | 19.60 |
Sep-6 | 19.88 | 19.59 | 19.96 | 19.26 |
Sep-9 | 19.53 | 19.66 | 19.92 | 19.43 |
Sep-10 | 19.72 | 19.37 | 19.73 | 19.21 |
Sep-11 | 19.22 | 19.46 | 19.54 | 19.00 |
Sep-12 | 19.60 | 20.29 | 20.70 | 19.59 |
Sep-13 | 20.33 | 20.22 | 20.54 | 20.03 |
Sep-16 | 20.38 | 20.44 | 20.79 | 19.98 |
Sep-17 | 20.62 | 20.44 | 20.79 | 20.33 |
Sep-18 | 20.44 | 20.43 | 20.79 | 20.15 |
Sep-19 | 20.90 | 21.36 | 21.36 | 20.78 |
Sep-20 | 21.43 | 20.78 | 21.67 | 20.73 |
Catalyst Pharmaceuticals Earnings
Catalyst Pharmaceuticals Earnings Report: Per Share Catalyst Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Catalyst Pharmaceuticals Forecast Revenue Growth
Catalyst Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Catalyst Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.10 per share, an increase this year of $0.05 per share, and an increase next year of $0.20 per share.
* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.